Enhanced and sustainable integrated laboratory services for HIV TB and other pathogens in nigeria (enhance)

Active Cooperative Agreement Awarded Last action

Award ID
NU2GGH002434
Recipient
Awarding agency
Obligated
$15,976,075

Award facts

Assistance listing
93.067 Global AIDS
Completion date 81% complete
Funding
  • $14,601,334.00 Federal
  • $1,374,741.00 Non-federal
Funding agency
Center for Global Health Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Nigeria

Award details come from USAspending.gov.

Description

Abstract
The institute of human virology as one of the leading CDC laboratory partners in nigeria for close to 18 years has built a robust laboratory infrastructure in close partnership with the government of nigeria. The proposed 'enhanced and sustainable integrated laboratory services for HIV, TB, and other pathogens in nigeria (enhance)' leverages on the efforts toward strengthening the laboratory system by ihvn to achieve an enhanced integrated diagnostic and disease surveillance (idds) already demonstrated through its support of the national reference lab during the covid-19 pandemic. At the core of this submission is the ability to provide data management and analytics to support enhance data use for efficiency and impact in sample transport, optimal quality testing and monitoring, return of results, quality improvement of laboratory processes, and optimized clinical-lab interface. In line with nigeria's three-tier structure engaging key actors at the federal, state, and the local government area (LGA) level, enhance will operate under the leadership of the government of nigeria and through the national reference labs (nrls), the CDC supported resilient network of molecular labs, clinical labs and HIV testing sites, to institutionalize a national model of laboratory network that provides high quality integrated laboratory diagnostic and surveillance services for TB and HIV diagnosis [HIV test and early infant diagnosis (EID)], monitoring for viral suppression (viral load (VL) including infant viral load (IVT), HIV drug resistance, diagnostics of other diseases of public health significance in partnership with the government of nigeria (GON) and with guidance from CDC. Enhance proposes to support the government of nigeria reach HIV epidemic control and strengthen IT response to TB and other diseases of public health significance on a backbone of an optimized centralized laboratory information management system that links data on tracking of sample receipt, testing, generation and return of test results, commodity utilization and tracking, and equipment utilization. Through the utilization of improved and expanded dash boards with real time or near real time information, enhance provides critical information for: 1) improved coordination, supervision and mentoring by appropriate agencies of the government of nigeria and health facilities; 2) expanded internal and external quality assurance processes leading to ISO accreditation of selected CDC supported molecular laboratories and national reference labs; 3) improved tracking of the staff level, retention, and progress in the career development of the trained lab work force; and 4) improved infection, prevention and control through occupational health, patient safety, and an effective waste management at CDC-supported laboratories. Through enhance, the improved public health national tiered laboratory network in nigeria is poised to implement an enhanced integrated diagnostics and disease surveillance (idds) led by the government of nigeria and guided by CDC.

Transactions

Action Obligated Date
Amendment $241,340
Amendment $191,656
Amendment $191,656
Amendment $120,963
Amendment $120,963
Amendment $120,963
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $145,911
Amendment $145,911
Amendment $145,911
Amendment $145,911
Amendment $145,911
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $1
Amendment $1
Amendment $1
Amendment $1
Amendment $1
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award NU2GGH002434?

NU2GGH002434 was awarded to Institute Of Human Virology NIG Ltdgte by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2022.

How much is award NU2GGH002434 worth?

$15,976,075 has been obligated on NU2GGH002434: $14,601,334 in federal funding and $1,374,741 in non-federal funding.

Which agency awarded NU2GGH002434?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded NU2GGH002434, with funding from Center for Global Health (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award